T. Rowe Price Associates’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-262,382
| Closed | -$4.18M | – | 2931 |
|
|
2021
Q1 | $4.18M | Sell |
262,382
-152,097
| -37% | -$2.42M | ﹤0.01% | 1503 |
|
|
2020
Q4 | $6.34M | Buy |
+414,479
| New | +$6.34M | ﹤0.01% | 1413 |
|
|
2018
Q3 | – | Sell |
-20,404
| Closed | -$5.59M | – | 2580 |
|
|
2018
Q2 | $5.59M | Buy |
20,404
+6,376
| +45% | +$1.75M | ﹤0.01% | 1423 |
|
|
2018
Q1 | $3.82M | Buy |
+14,028
| New | +$3.82M | ﹤0.01% | 1457 |
|
|
2017
Q4 | – | Sell |
-443
| Closed | -$89K | – | 2572 |
|
|
2017
Q3 | $89K | Hold |
443
| – | – | ﹤0.01% | 2487 |
|
|
2017
Q2 | $51K | Sell |
443
-1
| -0.2% | -$115 | ﹤0.01% | 2526 |
|
|
2017
Q1 | $71K | Hold |
444
| – | – | ﹤0.01% | 2517 |
|
|
2016
Q4 | $77K | Hold |
444
| – | – | ﹤0.01% | 2492 |
|
|
2016
Q3 | $109K | Sell |
444
-4
| -0.9% | -$982 | ﹤0.01% | 2432 |
|
|
2016
Q2 | $111K | Buy |
448
+3
| +0.7% | +$743 | ﹤0.01% | 2410 |
|
|
2016
Q1 | $161K | Buy |
445
+2
| +0.5% | +$724 | ﹤0.01% | 2333 |
|
|
2015
Q4 | $204K | Buy |
+443
| New | +$204K | ﹤0.01% | 2297 |
|
|
2015
Q3 | – | Sell |
-32,000
| Closed | -$27M | – | 2524 |
|
|
2015
Q2 | $27M | Buy |
32,000
+21,240
| +197% | +$17.9M | 0.01% | 1054 |
|
|
2015
Q1 | $10.8M | Buy |
+10,760
| New | +$10.8M | ﹤0.01% | 1319 |
|